Before that, India-made cough syrups were allegedly linked to children deaths in the Gambia and Uzbekistan last year...

The vaccine is now available on CoWIN and priced at Rs 800 for private markets and Rs 325 for the government of India and state governments...

The nasal vaccine -- BBV154 -- had received Drugs Controller General of India's approval in November for restricted emergency use among adults...

Bharat Biotech decision based on the uncertainty about where and under what conditions might the stolen vials get distributed...

The company's chief also said that the homegrown jab for lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month...

The top-line data from the immuno-bridging and broadening study will be critical to support Ocugen’s future plans for the development of Covaxin in United States...

According to respective company sources, 200 million doses of Corbevax while 50 million doses of Covaxin are ready to dispatch as and when orders are received...

Centre’s vaccine policy advisers earlier this week approved release of intranasal vaccine into the private market...

iNCOVACC is the world's first intranasal vaccine for Covid to receive approval for the primary two-dose schedule and as a heterologous booster dose...

Here are the latest developments from India and abroad...